Stanford lecturer to discuss autoimmune disease at CSUB

April 2, 2008
CONTACT:
Kathy Miller, 661/654-2456, kmiller26@csub.edu or
Michele Newel, 661/654-2720, mnewell1@csub.edu
 

California State University, Bakersfield's School of Natural Science and Mathematics presents its inaugural public seminar on Wednesday, April 9 at 4 p.m. in the Dezember Leadership Center, room 402.

Chaitan Khosla, chairman of the chemistry department and professor of chemical engineering at Stanford University, will be the guest lecturer. He will explore the auto immune disease celiac sprue in his discussion entitled "Celiac Sprue: Fundamental and Translational Investigations into an Orphan Disease."

Celiac sprue is an autoimmune disease of the small intestine that is triggered by gluten, a nutritionally important protein source in the human diet. People that suffer from celiac disease cannot fully digest food grains such as wheat, rye and barley.

Celiac disease is a gastrointestinal disease that afflicts roughly 1 in 100 individuals in the United States. Currently there is no therapeutic option available to treat celiac sprue patients other than a strict and lifelong adherence to avoiding gluten.

Khosla and his team are dedicated to researching this serious, but often overlooked disease. Their molecular approaches have uncovered new insights into the disease that are leading to new treatment approaches.

The seminar is being funded through a $400,000 National Science Foundation grant awarded to CSUB. The grant provides scholarships for CSUB science, math, and engineering majors and allows CSUB's School of Natural Sciences and Mathematics to offer a lecture series of interest to science students, faculty, and the general public. NSF is an independent federal agency created to promote the progress of science. The agency funds specific research proposals that have been judged the most promising by a rigorous and objective merit-review system.

For additional information, contact Tom Meyer at (661) 654-2104 or Roy LaFever (661) 654-2336.